|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Geiger TR and Peeper DS: Metastasis
mechanisms. Biochim Biophys Acta. 1796:293–308. 2009.PubMed/NCBI
|
|
3
|
Zhao Z, Zhu X, Cui K, Mancuso J, Federley
R, Fischer K, Teng GJ, Mittal V, Gao D, Zhao H, et al: In vivo
visualization and characterization of epithelial-mesenchymal
transition in breast tumors. Cancer Res. 76:2094–2104. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jefri M, Huang YN, Huang WC, Tai CS and
Chen WL: YKL-40 regulated epithelial-mesenchymal transition and
migration/invasion enhancement in non-small cell lung cancer. BMC
Cancer. 15:5902015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yu M, Bardia A, Wittner BS, Stott SL, Smas
ME, Ting DT, Isakoff SJ, Ciciliano JC, Wells MN, Shah AM, et al:
Circulating breast tumor cells exhibit dynamic changes in
epithelial and mesenchymal composition. Science. 339:580–584. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gandalovičová A, Vomastek T, Rosel D and
Brábek J: Cell polarity signaling in the plasticity of cancer cell
invasiveness. Oncotarget. Feb 8–2016.(Epub ahead of print). doi:
10.18632/oncotarget.7214. View Article : Google Scholar
|
|
7
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nalluri SM, O'Connor JW and Gomez EW:
Cytoskeletal signaling in TGFβ-induced epithelial-mesenchymal
transition. Cytoskeleton Hoboken. 72:557–569. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kalcheim C: Epithelial-mesenchymal
transitions during neural crest and somite development. J Clin Med.
5:52015. View Article : Google Scholar
|
|
10
|
Peng C, Li Z, Niu Z, Niu W, Xu Z, Gao H,
Niu W, Wang J, He Z, Gao C, et al: Norcantharidin suppresses colon
cancer cell epithelial-mesenchymal transition by inhibiting the
αvβ6-ERK-Ets1 signaling pathway. Sci Rep. 6:205002016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang C, Lu Y, Li Q, Mao J, Hou Z, Yu X,
Fan S, Li J, Gao T, Yan B, et al: Salinomycin suppresses
TGF-β1-induced epithelial-to-mesenchymal transition in MCF-7 human
breast cancer cells. Chem Biol Interact. 248:74–81. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang Y, Zhang X, Song D and Wei J: Piwil2
modulates the invasion and metastasis of prostate cancer by
regulating the expression of matrix metalloproteinase-9 and
epithelial-mesenchymal transitions. Oncol Lett. 10:1735–1740.
2015.PubMed/NCBI
|
|
13
|
Liu XN, Wang S, Yang Q, Wang YJ, Chen DX
and Zhu XX: ESC reverses epithelial mesenchymal transition induced
by transforming growth factor-β via inhibition of Smad signal
pathway in HepG2 liver cancer cells. Cancer Cell Int. 15:1142015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang L, Yang H, Lei Z, Zhao J, Chen Y,
Chen P, Li C, Zeng Y, Liu Z, Liu X, et al: Repression of TIF1γ by
SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in
non-small-cell lung cancer. Oncogene. 35:867–877. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Miao JW, Liu LJ and Huang J:
Interleukin-6-induced epithelial-mesenchymal transition through
signal transducer and activator of transcription 3 in human
cervical carcinoma. Int J Oncol. 45:165–176. 2014.PubMed/NCBI
|
|
16
|
Jia Z, Johnson AC, Wang X, Guo Z,
Dreisbach AW, Lewin JR, Kyle PB and Garrett MR: Allelic variants in
Arhgef11 via the Rho-Rock pathway are linked to
epithelial-mesenchymal transition and contributes to kidney injury
in the Dahl salt-sensitive rat. PLoS One. 10:e01325532015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Biondini M, Duclos G, Meyer-Schaller N,
Silberzan P, Camonis J and Parrini MC: RalB regulates
contractility-driven cancer dissemination upon TGFβ stimulation via
the RhoGEF GEF-H1. Sci Rep. 5:117592015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Oxford G and Theodorescu D: Ras
superfamily monomeric G proteins in carcinoma cell motility. Cancer
Lett. 189:117–128. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bellovin DI, Simpson KJ, Danilov T,
Maynard E, Rimm DL, Oettgen P and Mercurio AM: Reciprocal
regulation of RhoA and RhoC characterizes the EMT and identifies
RhoC as a prognostic marker of colon carcinoma. Oncogene.
25:6959–6967. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mukai M, Endo H, Iwasaki T, Tatsuta M,
Togawa A, Nakamura H and Inoue M: RhoC is essential for
TGF-beta1-induced invasive capacity of rat ascites hepatoma cells.
Biochem Biophys Res Commun. 346:74–82. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hakem A, Sanchez-Sweatman O, You-Ten A,
Duncan G, Wakeham A, Khokha R and Mak TW: RhoC is dispensable for
embryogenesis and tumor initiation but essential for metastasis.
Genes Dev. 19:1974–1979. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen M, Towers LN and O'Connor KL: LPA2
(EDG4) mediates Rho-dependent chemotaxis with lower efficacy than
LPA1 (EDG2) in breast carcinoma cells. Am J Physiol Cell Physiol.
292:C1927–C1933. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Batista FD, Treanor B and Harwood NE:
Visualizing a role for the actin cytoskeleton in the regulation of
B-cell activation. Immunol Rev. 237:191–204. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zarzynska JM: Two faces of TGF-beta1 in
breast cancer. Mediators Inflamm. 2014:1417472014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rho JK, Choi YJ, Lee JK, Ryoo BY, Na II,
Yang SH, Kim CH and Lee JC: Epithelial to mesenchymal transition
derived from repeated exposure to gefitinib determines the
sensitivity to EGFR inhibitors in A549, a non-small cell lung
cancer cell line. Lung Cancer. 63:219–226. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim S, Lee J, Jeon M, Nam SJ and Lee JE:
Elevated TGF-β1 and -β2 expression accelerates the epithelial to
mesenchymal transition in triple-negative breast cancer cells.
Cytokine. 75:151–158. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang Y, Yan W and Chen X: Mutant p53
disrupts MCF-10A cell polarity in three-dimensional culture via
epithelial-to-mesenchymal transitions. J Biol Chem.
286:16218–16228. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ko H, Jeon H, Lee D, Choi HK, Kang KS and
Choi KC: Sanguiin H6 suppresses TGF-β induction of the
epithelial-mesenchymal transition and inhibits migration and
invasion in A549 lung cancer. Bioorg Med Chem Lett. 25:5508–5513.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li L, Qi L, Liang Z, Song W, Liu Y, Wang
Y, Sun B, Zhang B and Cao W: Transforming growth factor-β1 induces
EMT by the transactivation of epidermal growth factor signaling
through HA/CD44 in lung and breast cancer cells. Int J Mol Med.
36:113–122. 2015.PubMed/NCBI
|
|
30
|
Kasai H, Allen JT, Mason RM, Kamimura T
and Zhang Z: TGF-beta1 induces human alveolar epithelial to
mesenchymal cell transition (EMT). Respir Res. 6:562005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Miettinen PJ, Ebner R, Lopez AR and
Derynck R: TGF-beta induced transdifferentiation of mammary
epithelial cells to mesenchymal cells: Involvement of type I
receptors. J Cell Biol. 127:2021–2036. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Manelli-Oliveira R and Machado-Santelli
GM: Cytoskeletal and nuclear alterations in human lung tumor cells:
A confocal microscope study. Histochem Cell Biol. 115:403–411.
2001.PubMed/NCBI
|
|
33
|
Lee MY, Chou CY, Tang MJ and Shen MR:
Epithelial-mesenchymal transition in cervical cancer: Correlation
with tumor progression, epidermal growth factor receptor
overexpression, and snail up-regulation. Clin Cancer Res.
14:4743–4750. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Graham TR, Zhau HE, Odero-Marah VA,
Osunkoya AO, Kimbro KS, Tighiouart M, Liu T, Simons JW and O'Regan
RM: Insulin-like growth factor-I-dependent up-regulation of ZEB1
drives epithelial-to-mesenchymal transition in human prostate
cancer cells. Cancer Res. 68:2479–2488. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Peinado H, Portillo F and Cano A:
Transcriptional regulation of cadherins during development and
carcinogenesis. Int J Dev Biol. 48:365–375. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gjerdrum C, Tiron C, Høiby T, Stefansson
I, Haugen H, Sandal T, Collett K, Li S, McCormack E, Gjertsen BT,
et al: Axl is an essential epithelial-to-mesenchymal
transition-induced regulator of breast cancer metastasis and
patient survival. Proc Natl Acad Sci USA. 107:1124–1129. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yang MH, Chen CL, Chau GY, Chiou SH, Su
CW, Chou TY, Peng WL and Wu JC: Comprehensive analysis of the
independent effect of twist and snail in promoting metastasis of
hepatocellular carcinoma. Hepatology. 50:1464–1474. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yi EY, Park SY, Jung SY, Jang WJ and Kim
YJ: Mitochondrial dysfunction induces EMT through the
TGF-β/Smad/Snail signaling pathway in Hep3B hepatocellular
carcinoma cells. Int J Oncol. 47:1845–1853. 2015.PubMed/NCBI
|
|
39
|
Brivio S, Cadamuro M, Fabris L and
Strazzabosco M: Epithelial-to-mesenchymal transition and cancer
invasiveness: What can we learn from cholangiocarcinoma? J Clin
Med. 4:2028–2041. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kaibuchi K, Kuroda S and Amano M:
Regulation of the cytoskeleton and cell adhesion by the Rho family
GTPases in mammalian cells. Annu Rev Biochem. 68:459–486. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Pignatelli J, Tumbarello DA, Schmidt RP
and Turner CE: Hic-5 promotes invadopodia formation and invasion
during TGF-β-induced epithelial-mesenchymal transition. J Cell
Biol. 197:421–437. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yang H, Zhou J, Mi J, Ma K, Fan Y, Ning J,
Wang C, Wei X, Zhao H and Li E: HOXD10 acts as a tumor-suppressive
factor via inhibition of the RHOC/AKT/MAPK pathway in human
cholangiocellular carcinoma. Oncol Rep. 34:1681–1691.
2015.PubMed/NCBI
|
|
43
|
Symons M and Segall JE: Rac and Rho
driving tumor invasion: Who's at the wheel? Genome Biol.
10:2132009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Patel S, Takagi KI, Suzuki J, Imaizumi A,
Kimura T, Mason RM, Kamimura T and Zhang Z: RhoGTPase activation is
a key step in renal epithelial mesenchymal transdifferentiation. J
Am Soc Nephrol. 16:1977–1984. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
He X, Qian Y, Cai H, Yang S, Cai J and
Wang Z: RhoC is essential in TGF-β1 induced epithelial-mesenchymal
transition in cervical cancer cells. Oncol Lett. 10:985–989.
2015.PubMed/NCBI
|
|
46
|
Cho HJ and Yoo J: Rho activation is
required for transforming growth factor-beta-induced
epithelial-mesenchymal transition in lens epithelial cells. Cell
Biol Int. 31:1225–1230. 2007. View Article : Google Scholar : PubMed/NCBI
|
